Luke Halpern, Assistant Editor

Pharmacists will likely be the first contact for many affected patients, and they should be able to provide evidence-based advice on how to manage their infection.

Despite suggestions to the contrary in previously conducted small clinical trials, montelukast did not provide benefit in patients with COVID-19 symptoms.

Comprising most cases of this rare form of lymphoma, it is essential that pharmacists and treatment providers are aware of the health-related burdens patients with these subtypes consistently face.

Data presented at IDWeek also showed greater disease-prevention effects in the community with PCV21 compared with prior pneumococcal vaccines.

Therapy-related complications, in addition to financial obstacles, can complicate myasthenia gravis treatment.

The diagnostic test is a companion to vorasidenib, an isocitrate dehydrogenase inhibitor that received FDA approval this past summer.

A dedicated community pharmacist for over 40 years, Kessler has witnessed immense change and innovation throughout his career.

Recognizing repeat dosing efforts is important to improving outcomes in patients with Guillain-Barré syndrome who do not respond to IVIG.

Compared with brentuximab vedotin and chemotherapy, nivolumab and chemotherapy had longer progression-free survival and a better safety profile.

The increase was observed across multiple subgroups, including those with overweight or obesity and hospitalized patients.

The results indicate the potential use of loncastuximab tesirine as a treatment option for the rare hyperinflammatory condition.

Glucocorticoids improved outcomes for patients with Kawasaki disease at high risk of IVIG resistance without glucocorticoid-related adverse effects.

High-resolution scans can provide a picture of a patient’s brain that typical MRIs cannot, allowing for more detailed insights into the neurological effects of COVID-19.

The exemption allows more time for partners to adhere to enhanced distribution security requirements in the Food, Drug, & Cosmetics Act and prevents possible supply chain disruptions.

CAR T-cell therapy on an outpatient basis could lead to greater adherence and less financial and physical burdens.

The regulatory action is based on a positive preliminary analysis of the VANTAGE trial.

The discovery marks the first time an antibody has been observed to both assist and block viral infection with SARS-CoV-2.

Vaccine gap closure programs in Missouri and California provide a blueprint for a successful campaign.

Though both treatments come with positives and negatives, ultimately, individual patient clinical presentation and accessibility will determine the proper treatment for myasthenic crisis.

Significant polarization surrounding COVID-19 vaccinations in late 2020 and early 2021 looked to have had an impact in increasing vaccine hesitancy.

The results show promise for the use of Bruton tyrosine kinase inhibitors in non-Hodgkin lymphoma treatment.

The treatment aims to reduce prolonged QTc interval in patients with long QT syndrome.

The new screening test provides an easier, convenient option for patients seeking to screen themselves for colorectal cancer.

Major biomarkers for cognitive impairment were observed in hospitalized patients with neurological symptoms.

By utilizing a lower dose, patients can avoid potential adverse events and high financial burden.

As American Pharmacists Month begins, Alan Corley talks the importance of pharmacists and the value of the profession personally and to the overall community.

Positive trial results laid the groundwork for the designation.

Patients exhibited improved disease-free progression with minimal adverse effects.

The weight loss drug continues to show promise in treating a variety of other conditions.

The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.